Pharmaceutical Development and Technology

Papers
(The H4-Index of Pharmaceutical Development and Technology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Insights into tablet sticking: a quantitative case study with an ibuprofen and methocarbamol-based formulation65
Influence of punch coating surface properties on sticking during the tableting process30
Facile fabrication of degradable, serrated polyethylene diacrylate microneedles using stereolithography28
Development of PLGA-SPC3 functionalized gefitinib mesoporous silica nano-scaffolds for breast cancer targeting: biodistribution and cytotoxicity analysis25
Formulation and characterization of a fixed-dose microemulsion containing efavirenz, emtricitabine, and tenofovir25
Gum tragacanth-based hemostatic sponge for enhanced hemostasis in dental surgery24
Novel vanillic acid-loaded in situ gels: development, characterization, in vitro evaluation for enhanced w22
Cationic Okra gum coated nanoliposomes as a pH-sensitive carrier for co-delivery of hesperetin and oxaliplatin in colorectal cancers22
Formulation and optimization of a single-layer coat for targeting budesonide pellets to the descending Colon22
Fabrication and characterization of Coenzyme Q10-loaded nanofibers for potential biomedical applications20
Study on preparation and pharmacokinetics of gentiopicroside sustained release preparation19
Bortezomib/SBE-β-cyclodextrin inclusion complex for improved anticancer performance: formulation, characterization, and biological evaluation18
Scale-up in twin-screw wet granulation: impact of formulation properties17
Comparison study of physicochemical and biopharmaceutics properties of hydrophobic drugs ground by two dry milling processes17
Galactosylated bilosomes for liver-targeted delivery of ledipasvir: optimization, conjugate synthesis, and cellular evaluation16
Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats16
Formulation development, characterization, and evaluation of bedaquiline fumarate – Soluplus ® – solid dispersion16
Tumor cell membrane-camouflaged nanoparticles co-delivering docetaxel and metformin for enhanced synergistic therapy of HER2-positive breast cancer16
0.20278096199036